Omega Healthcare InvestorsBSP:O2HI34 -0.03%49 Return-on-Tangible-Equity is 13.02% as of Mar. 2026, which is 16% above its 10-year median of 11.23. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$60.64 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 932 REITs companies, Omega Healthcare Investors ranks better than 86.37% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Omega Healthcare Investors's annualized net income for the quarter that ended in Mar. 2026 was R$3,160 Mil. Omega Healthcare Investors's average shareholder tangible equity for the quarter that ended in Mar. 2026 was R$24,265 Mil. Therefore, Omega Healthcare Investors's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 13.02%.
The historical rank and industry rank for Omega Healthcare Investors's Return-on-Tangible-Equity or its related term are showing as below:
BSP:O2HI34'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.28 Med: 11.23 Max: 14.42
Current: 14.42
During the past 13 years, Omega Healthcare Investors's highest Return-on-Tangible-Equity was 14.42%. The lowest was 3.28%. And the median was 11.23%.
BSP:O2HI34's Return-on-Tangible-Equity is ranked better than 86.37% of 932
companies
in the REITs industry
Industry Median: 6.34
vs BSP:O2HI34: 14.42
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Omega Healthcare Investors Return-on-Tangible-Equity Related Terms
Omega Healthcare Investors Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:O2HI34 vs DOC, AHR, CTRE: Return-on-Tangible-Equity Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors Return-on-Tangible-Equity vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.02% mean?
Omega Healthcare Investors (BSP:O2HI34) has a Return-on-Tangible-Equity of 13.02% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Omega Healthcare Investors and its competitors. This is 16% above median its historical median of 11.23. Over the past decade, Omega Healthcare Investors' Return-on-Tangible-Equity has ranged from 3.28 to 14.42. According to the industry distribution chart, Omega Healthcare Investors ranks #127 out of 932 companies in the REITs industry, placing it in the top 13.6%.
Is Omega Healthcare Investors' Return-on-Tangible-Equity too high?
Omega Healthcare Investors' current Return-on-Tangible-Equity of 13.02% is 16% above median its 10-year median of 11.23. Over the past 10 years, this metric has ranged from a low of 3.28 to a high of 14.42. The REITs industry median Return-on-Tangible-Equity is 6.34. Omega Healthcare Investors' value of 13.02% is 105.4% above this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #127 out of 932 companies in the REITs industry, which is in the top quartile — a strong position relative to peers. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Return-on-Tangible-Equity compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #127 out of 932 companies for Return-on-Tangible-Equity. This places Omega Healthcare Investors in the top 14% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 6.34. Omega Healthcare Investors' value of 13.02% is 105.4% above this benchmark. Historically, Omega Healthcare Investors' own Return-on-Tangible-Equity has ranged from 3.28 to 14.42 over the past decade. While the company's 10-year median is 11.23 vs. the industry median of 6.34, Omega Healthcare Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a REITs company?
The median Return-on-Tangible-Equity among REITs companies is 6.34, based on 932 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current Return-on-Tangible-Equity of 13.02% is 105.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median Return-on-Tangible-Equity is 6.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current Return-on-Tangible-Equity is 13.02%, which is 16% above median its own 10-year median of 11.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Return-on-Tangible-Equity is 13.02%, which is 16% above median its 10-year median of 11.23 and 105.4% above the REITs industry median of 6.34. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Return-on-Tangible-Equity is 13.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
Return-on-Tangible-Equity: 13.02% (16% above median its 10-year median of 11.23)
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
Industry Position: 105.4% above the REITs median (#127 of 932)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
